CIBC Private Wealth Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.56K | Sell |
119
-156
| -57% | -$3.29K | ﹤0.01% | 2763 |
|
|
2025
Q3 | $5.3K | Buy |
275
+24
| +10% | +$428 | ﹤0.01% | 2546 |
|
|
2025
Q2 | $4.29K | Sell |
251
-267
| -52% | -$11.4K | ﹤0.01% | 2483 |
|
|
2025
Q1 | $25.5K | Buy |
518
+5
| +1% | +$526 | ﹤0.01% | 1909 |
|
|
2024
Q4 | $64.8K | Sell |
513
-187
| -27% | -$22.9K | ﹤0.01% | 1584 |
|
|
2024
Q3 | $87.4K | Buy |
700
+236
| +51% | +$32.6K | ﹤0.01% | 1546 |
|
|
2024
Q2 | $70.3K | Sell |
464
-8
| -2% | -$1.03K | ﹤0.01% | 1533 |
|
|
2024
Q1 | $60.6K | Buy |
+472
| New | +$57.8K | ﹤0.01% | 1595 |
|
|
2022
Q4 | – | Sell |
-8,525
| Closed | -$942K | – | 932 |
|
|
2022
Q3 | $942K | Buy |
8,525
+8,519
| +141,983% | +$859K | ﹤0.01% | 599 |
|
|
2022
Q2 | $0 | Buy |
+6
| New | +$441 | ﹤0.01% | 1292 |
|
|
2021
Q2 | – | Sell |
-2,732
| Closed | -$204K | – | 1066 |
|
|
2021
Q1 | $204K | Sell |
2,732
-1,456
| -35% | -$134K | ﹤0.01% | 990 |
|
|
2020
Q4 | $714K | Sell |
4,188
-1,352
| -24% | -$200K | ﹤0.01% | 699 |
|
|
2020
Q3 | $778K | Buy |
+5,540
| New | +$842K | ﹤0.01% | 603 |
|
|
2020
Q2 | – | Sell |
-6,549
| Closed | -$641K | – | 787 |
|
|
2020
Q1 | $641K | Sell |
6,549
-939
| -13% | -$107K | ﹤0.01% | 577 |
|
|
2019
Q4 | $966K | Sell |
7,488
-123
| -2% | -$12.4K | ﹤0.01% | 585 |
|
|
2019
Q3 | $573K | Sell |
7,611
-567
| -7% | -$67K | ﹤0.01% | 668 |
|
|
2019
Q2 | $1.24M | Sell |
8,178
-919
| -10% | -$112K | ﹤0.01% | 533 |
|
|
2019
Q1 | $1.08M | Buy |
9,097
+387
| +4% | +$49.8K | ﹤0.01% | 573 |
|
|
2018
Q4 | $951K | Sell |
8,710
-585
| -6% | -$73.2K | ﹤0.01% | 574 |
|
|
2018
Q3 | $1.5M | Buy |
9,295
+145
| +2% | +$19.8K | 0.01% | 586 |
|
|
2018
Q2 | $1.21M | Sell |
9,150
-130
| -1% | -$12.3K | ﹤0.01% | 612 |
|
|
2018
Q1 | $688K | Sell |
9,280
-600
| -6% | -$40K | ﹤0.01% | 716 |
|
|
2017
Q4 | $550K | Buy |
9,880
+190
| +2% | +$10.1K | ﹤0.01% | 761 |
|
|
2017
Q3 | $440K | Buy |
+9,690
| New | +$387K | ﹤0.01% | 791 |
|
Other funds holding SRPT
EAM
